Novel salmon cardiac peptide hormone is released from the ventricle by regulated secretory pathway KATI KOKKONEN,1 HEIDI VIERIMAA,1 SARI BERGSTRÖM,1 VIRPI TERVONEN,1 OLLI ARJAMAA,2 HEIKKI RUSKOAHO,3 MATTI JÄRVILEHTO,4 AND OLLI VUOLTEENAHO1

Kokkonen, Kati, Heidi Vierimaa, Sari Bergström, Virpi Tervonen, Olli Arjamaa, Heikki Ruskoaho, Matti Järvilehto, and Olli Vuolteenaho. Novel salmon cardiac peptide hormone is released from the ventricle by regulated secretory pathway. Am. J. Physiol. Endocrinol. Metab. 278: E285–E292, 2000.—We used the secretion of the novel salmon cardiac peptide (sCP) as a model to examine the mechanisms of ventricular hormone release. Mechanical load increased dose dependently the secretion of immunoreactive sCP from isolated perfused salmon ventricle, with 3.3-fold increase when a load of 13 cmH2O was applied. Endothelin-1 (5 nmol/l) was also able to rapidly increase the secretion of sCP. The released peptide corresponded to the biologically active sCP29, whereas the large ventricular storage consisted of pro-sCPsized material. With the use of immunoelectron microscopy, a large number of granules containing immunoreactive sCP could be detected in salmon ventricle. As judged by RNA blot analysis, there was very active basal expression of the sCP gene in the ventricle, which was not increased by mechanical load of up to 2-h duration. Our results show that the ventricle actively expresses the gene of sCP, stores the prohormone in secretory granules, and releases the peptide in response to mechanical load and endothelin-1. Thus the salmon ventricle uses the regulated pathway to produce and release a hormone structurally related to the mammalian natriuretic peptides.